Simultaneous reduction of flow and fraction of inspired oxygen (FiO2) versus reduction of flow first or FiO2 first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial)

Abstract Background High-flow nasal cannula (HFNC) oxygen therapy has been widely used in critically ill patients. Despite the effectiveness of HFNC as a treatment, optimal methods to withdraw HFNC after recovery from preexisting conditions have not been investigated to date. In this study, we will...

Full description

Bibliographic Details
Main Authors: Min Chul Kim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Choon-Taek Lee, Jae Ho Lee, Eun Sun Kim
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-019-4019-7

Similar Items